Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-02-28 @ 12:03 AM
Study NCT ID:
NCT02602067
Status:
TERMINATED
Last Update Posted:
2018-09-18
First Post:
2015-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Sponsor:
sigma-tau i.f.r. S.p.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Neoplasm | View |
| None | Head and Neck Neoplasm | View |
| None | Skin Neoplasm | View |
| None | Respiratory Tract Neoplasm | View |
| None | Urogenital Neoplasm | View |
| None | Digestive System Neoplasm | View |
| None | Pancreatic Neoplasm | View |
| None | Connective and Soft Tissue Neoplasm | View |
| None | Lymphoma, Non-Hodgkin | View |
Keywords: